Anixa Biosciences (ANIX) Convertible Debt (2012 - 2014)

Anixa Biosciences (ANIX) has reported Convertible Debt for 3 consecutive years, with $1.8 million the latest figure, recorded in Q3 2014.

• For the quarter ending Q3 2014, Convertible Debt rose 289.76% year-over-year to $1.8 million; the trailing twelve-month figure through Jul 2014 stood at $1.8 million (up 289.76% YoY), and the FY2013 full-year result was $548598.0, up 1599.87% from the prior year.
• Convertible Debt advanced to $1.8 million in Q3 2014 per ANIX's latest filing, from $1.6 million in the prior quarter.
• Across five years, Convertible Debt topped out at $1.8 million in Q3 2014 and bottomed at $32273.0 in Q4 2012.
• Historically, Convertible Debt has averaged $848545.8 across 3 years, with a median of $501088.5 in 2013.
• The sharpest annual moves came in 2013 and 2014: Convertible Debt surged 1599.87% in 2013, then soared 258.81% in 2014.
• Over 3 years, Convertible Debt stood at $32273.0 in 2012, then soared by 1599.87% to $548598.0 in 2013, then surged by 220.11% to $1.8 million in 2014.
• According to Business Quant data, Convertible Debt over the past three periods registered $1.8 million, $1.6 million, and $1.5 million for Q3 2014, Q2 2014, and Q1 2014 respectively.